Intelligence Platform
Patents
Browse 774 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8945508
Dendrimer compositions and methods of synthesis
granted patentUS 8940301
Breast tumor treatment with anti-CXCR1 compositions
granted patentUS 8940701
Compounds for, and methods of, treating cancer and inhibiting invasion and metastases
granted patentUS 8936794
Conducting polymer nanotube actuators for precisely controlled release of medicine and bio
granted patentUS 8932583
Scaffolds for cell transplantation
granted patentUS 8927528
Composition for treating hearing loss
granted patentUS 8912323
Multifunctional small molecules
granted patentUS 8911729
Stem cell factor inhibitor
granted patentUS 8906343
PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and phot
granted patentUS 8901117
Small molecule inhibitors of MDM2 and the uses thereof
granted patentUS 8901276
Peptide reagents and methods for detection of colon dysplasia
granted patentUS 8889635
Dendrimer conjugates
granted patentUS 8889672
Compounds, formulations, and methods of protein kinase C inhibition
granted patentUS 8883771
Bivalent inhibitors of IAP proteins and therapeutic methods using the same
granted patentUS 8877796
Spiro-oxindole MDM2 antagonists
granted patentUS 8877208
Multivalent nanoemulsion vaccines
granted patentUS 8865750
Small molecule inhibitors of RGS proteins
granted patentUS 8865867
Lectins and uses thereof
granted patentUS 8852568
Compositions and methods for treating and preventing skeletal muscle deficiencies
granted patentUS 8853151
Pro-drug complexes and related methods of use
granted patentUS 8846684
Arbovirus inhibitors and uses thereof
granted patentUS 8846889
Peptide biosynthesis and pain therapy
granted patentUS 8815927
Bivalent diazo bicyclic Smac mimetics and the uses thereof
granted patentUS 8815845
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
granted